Page 6 of Biocon

Pharma shares to continue surging despite rich valuations; HSBC lists top stock picks

Even after pharma stocks witnessed a massive bull run in 2020 and valuations seem quite rich at this juncture, global…

January 22, 2021 13:42 IST

MTAR Technologies, MTAR Tech IPO, MTAR Tech grey market premium

Stocks in focus today: TCS, Vodafone Idea, State Bank of India, Tata Power, Biocon

Nifty futures were trading 32.50 points up at 14,287.50 on Singaporean Exchange, suggesting a gap-up start for BSE Sensex and…

January 8, 2021 08:48 IST

Stocks in focus: Wipro, PNB, HDFC Bank, Biocon, AU Small Finance Bank, ICICI Prudential Life Insurance

Nifty futures were trading 35 points or 0.25 per cent up at 14,005, suggesting a record high opening for BSE…

December 29, 2020 08:44 IST

Roshni Nadar, Hurun List, Kotak Wealth Hurun Wealthy Women 2020

HCL Tech’s Roshini Nadar India’s richest women in 2020; check 10 richest women on Hurun rich list

HCL Technologies’ Chairperson Roshini Nadar Malhotra topped the Kotak Wealth Hurun Wealthy Women 2020 list, with total wealth of Rs…

Updated: December 3, 2020 14:58 IST

Biocon share price hits fresh record high as Itolizumab drug gets DCGI nod for COVID-19 treatment

Biocon share price touched a 52-week low of Rs 211.30 apiece in August 2019, since then the stock price has…

July 13, 2020 11:24 IST

Mylan and Biocon to present phase-III trastuzumab biosimilar data at ASCO annual meeting

HERITAGE study shows comparable efficacy, safety and immunogenicity to branded trastuzumab in HER2-positive metastatic breast cancer patients

June 6, 2016 14:26 IST

Biocon shares hit 52-week high, here is why

Biocon shares surged after global pharma major Mylan Inc, and the Indian pharma company confirmed the efficacy and safety of…

Updated: June 6, 2016 17:16 IST

Mylan, Biocon confirm efficacy of trastuzumab biosimilar

Global pharma major Mylan Inc, and Biocon have confirmed the efficacy and safety of MYL-1401O, a proposed biosimilar trastuzumab co-developed…

June 4, 2016 16:48 IST

Biocon to invest Rs 1,060 crores in Bengaluru plant

The facility is expected to generate at least 750 jobs immediately

May 26, 2016 17:51 IST

Delhi HC refrains from staying single judge interim order over breast cancer drug by Biocon and Mylan

The division bench of the high court, however, said the drug-makers may continue to sell their products under the brand…

April 29, 2016 10:49 IST

Maruti Suzuki, HCL Tech, Yes Bank among 8 stocks that trended in Thursday’s trade

Maruti Suzuki shares closed 2.94 per cent down at Rs 3748.45 after Japense yen soared almost 3 per cent against…

Updated: April 28, 2016 17:46 IST

Exceptional income drives Biocon Q4 net up 79 % at Rs 361 crore

Biotechnology major Biocon today reported 79 per cent jump in consolidated net profit at Rs360.9 crore for the fourth quarter…

Updated: April 27, 2016 16:29 IST

Biocon Q4 net profit jumps 79 pc to Rs 361 cr on higher sales, exceptional income

Biotechnology firm Biocon reported a 79.1 per cent increase in its net profit at Rs 360.9 crore for the fourth…

April 27, 2016 13:54 IST

Biocon Inc recalls 5,505 bottles of Simvastatin tablets in US

Biocon Inc, part of biotechnology major Biocon, is recalling in the US 5,505 bottles of cholesterol lowering Simvastatin tablets for…

April 20, 2016 20:53 IST

Top 10 business news today: Arun Jaitley warns Vijay Mallya over debt recovery, Tata Sons to hike AirAsia India stake, Xiaomi Mi 5 to be launched soon, Tata tiago, more

Prime Minister Narendra Modi on Monday said the growth in the Indian economy was led by some of the reforms…

March 29, 2016 11:16 IST

In a first, Biocon insulin gets Japan nod

Bio-pharma major Biocon on Monday became the first Indian company to receive regulatory approval for a biosimilar insulin in Japan.

March 29, 2016 01:18 IST

Biocon’s Insulin Glargine receives regulatory approval in Japan

The product is ready to be launched in Q1 FY17

March 28, 2016 17:23 IST

Biocon in co-development and commercialisation agreement with Lab PiSA

The collaboration is part of Biocon’s strategy to address the large demand for generic rh-insulin in the US

March 18, 2016 12:02 IST

Related News

Asia Cup Trophy Controversy: India refuses award, PCB proposes special handover

Asia Cup 2025 Trophy row: PCB chief Mohsin Naqvi sends firm message to BCCI, says ‘If you want the trophy, we…’

Four big companies have now stopped sponsoring H-1B visas. Here is the full list

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar link and KYC rules explained

Aadhaar card update new rules from November 2025: You won’t need to upload documents anymore — here’s how to change your details online

Inside Kangana Ranaut’s opulent Delhi home and her vibrant Diwali celebrations: ‘Interiors better than Kapoors-Khans,’ say netizens

Techie discusses move back to India amid Green Card concerns.

Techie plans return to India after 15 years in US amid green card uncertainty, says ‘want to move before…’

3 ‘Buy’ recommendations by Jefferies, with up to 34% upside potential

Market9 min ago

Jefferies, a global brokerage firm, has identified three key stocks for investors to focus on with potential upside of up to 34%. Hindustan Unilever, Colgate-Palmolive, and Sunteck Realty have all been given a ‘Buy’ rating by the brokerage, citing growth potential, margin improvement, and steady business fundamentals.

View all shorts

Photo Gallery

In Images | Delhi struggles with waterlogging as rains hit festival season plans

3 weeks agoSeptember 30, 2025

View All

Page 6 of Biocon

Related News

Photo Gallery

In Images | Delhi struggles with waterlogging as rains hit festival season plans

Trending Topics